Deans' stroke musings: AI tool improves stroke care and outcomes, study finds

Changing stroke rehab and research worldwide now.Time is Brain! trillions and trillions of neurons that DIE each day because there are NO effective hyperacute therapies besides tPA(only 12% effective). I have 523 posts on hyperacute therapy, enough for researchers to spend decades proving them out. These are my personal ideas and blog on stroke rehabilitation and stroke research. Do not attempt any of these without checking with your medical provider. Unless you join me in agitating, when you need these therapies they won't be there.

What this blog is for:

My blog is not to help survivors recover, it is to have the 10 million yearly stroke survivors light fires underneath their doctors, stroke hospitals and stroke researchers to get stroke solved. 100% recovery. The stroke medical world is completely failing at that goal, they don't even have it as a goal. Shortly after getting out of the hospital and getting NO information on the process or protocols of stroke rehabilitation and recovery I started searching on the internet and found that no other survivor received useful information. This is an attempt to cover all stroke rehabilitation information that should be readily available to survivors so they can talk with informed knowledge to their medical staff. It lays out what needs to be done to get stroke survivors closer to 100% recovery. It's quite disgusting that this information is not available from every stroke association and doctors group.

Monday, March 23, 2026

AI tool improves stroke care and outcomes, study finds

'Care' might be better but SURVIVORS DEMAND RECOVERY! When the hell will you GET THERE?

AI tool improves stroke care and outcomes, study finds

An AI tool used to assess stroke scans was linked to better stroke care(NOT RECOVERY!) and improved long-term outcomes in a large trial.

The system used AI-assisted imaging analysis to classify the causes of a stroke alongside evidence-based treatment recommendations, and was tested against usual care(NOT RECOVERY!) in routine clinical practice.

The trial involved 21,603 patients with acute ischaemic stroke, a stroke caused by a blood clot blocking blood flow to the brain, who were admitted to one of 77 hospitals across China within seven days of symptom onset. The average age was 67 and 36 per cent were female.

From January 2021 to June 2023, 11,054 patients at 38 hospitals received support from the stroke clinical decision support system, or CDSS, while 10,549 patients at 39 hospitals received usual medical care(NOT RECOVERY!).

Physicians using the system received training, and factors including hospital region and grade, patient age, medication history and lifestyle were taken into account.

Patients supported by the CDSS had fewer new vascular events, including stroke, heart attack or related death, at three, six and 12 months.

At three months, new vascular events occurred in 2.9 per cent of the intervention group compared with 3.9 per cent of the control group, representing a 26 per cent reduction.

This reduction was maintained at 12 months, with new vascular events occurring in 4 per cent of the intervention group versus 5.5 per cent of the control group, a 27 per cent reduction.

Patients receiving the intervention also recorded higher stroke care(NOT RECOVERY!) quality performance measures than those in the control group, at 91.4 per cent versus 89.8 per cent.

There were no significant differences between the two groups for disability and all-cause mortality at three, six and 12 months. There were also no significant differences in moderate or severe bleeding, or all bleeding, between the groups at any of these time points.

The authors noted limitations, including that the trial randomised hospitals rather than individual patients, and that differences in care(NOT RECOVERY!) patterns and subsequent outpatient care(NOT RECOVERY!) might have affected the findings.

However, they said the system was easy to use and was integrated into all hospital information systems, so it could serve as an AI-based comprehensive management tool focused on in-hospital care(NOT RECOVERY!) and secondary prevention strategies.

The authors concluded: “The stroke CDSS offers a promising approach to providing high quality care(NOT RECOVERY!) for patients with acute ischaemic stroke admitted to hospital, particularly for resource constrained regions with a heavy burden of cerebrovascular diseases like China.”

The researchers added that the tool “offers a more efficient and scalable method for improving stroke care(NOT RECOVERY!) and prognosis, with the added benefits of lower cost and greater sustainability.”